Fig A. Standardized cumulative incidence and 95% CI of inflammatory bowel disease in individuals with a GI biopsy result of normal mucosa (pink) and their matched population references (blue), stratified by sex, age at index date, or calendar period at index date. Table A. ICD codes and SNOMED codes defining IBD. Table B. Definitions of endoscopy, colectomy, and proctocolectomy. Table C. ICD codes assigned for phenotypes of IBD. Table D. Anatomical Therapeutic Chemical codes representing IBD treatment. Table E. Incidence rate of IBD in individuals with a GI biopsy result of normal mucosa and their matched population references. Table F. Incidence rate of IBD in individuals with a GI biopsy result of normal mucosa and their unexposed full si...
BACKGROUND: Data evaluating the chronological order of appearance of extraintestinal manifestations ...
Table S1. Characteristics of patients with IBD resident in Tuscany in 2000–2016 (N = 1584). (DOCX 12...
BACKGROUND: Data evaluating the chronological order of appearance of extraintestinal manifestations ...
The cumulative incidence was estimated from the flexible parametric survival model conditioned on ma...
Table S1. Patient characteristics. Table S2. Detailed patient characteristics and diagnosis. Table S...
Figure S1. Incidence of colitis. Figure S2. Flow chart of endoscopic findings, histologic features, ...
NIDDK IBD Genetic Consortium Phenotype Operating Manual. The Phenotype Operating Manual helped to es...
Aim: To investigate inflammatory bowel disease (IBD) register-based subtype classifications over a p...
De novo and rarefy analysis. Contains a table that compares results from the generalized estimating ...
Additional file 1: Table S1. [STROBE-MR checklist of Mendelian randomization study]. Table S2. [Char...
Additional file 1: Table S1. Phenotype descriptions and distributions. Table S2A. Characteristics of...
IBD during follow-up in individuals with a lower GI biopsy result of normal mucosa.</p
Estimated odds of serious infection for treatment strategies compared to aminosalicylates or antibio...
markdownabstractInflammatory Bowel Disease (IBD) is a chronic disabling disease of the gastrointesti...
Estimated odds of serious infection for treatment strategies compared to other immunosuppressants. (...
BACKGROUND: Data evaluating the chronological order of appearance of extraintestinal manifestations ...
Table S1. Characteristics of patients with IBD resident in Tuscany in 2000–2016 (N = 1584). (DOCX 12...
BACKGROUND: Data evaluating the chronological order of appearance of extraintestinal manifestations ...
The cumulative incidence was estimated from the flexible parametric survival model conditioned on ma...
Table S1. Patient characteristics. Table S2. Detailed patient characteristics and diagnosis. Table S...
Figure S1. Incidence of colitis. Figure S2. Flow chart of endoscopic findings, histologic features, ...
NIDDK IBD Genetic Consortium Phenotype Operating Manual. The Phenotype Operating Manual helped to es...
Aim: To investigate inflammatory bowel disease (IBD) register-based subtype classifications over a p...
De novo and rarefy analysis. Contains a table that compares results from the generalized estimating ...
Additional file 1: Table S1. [STROBE-MR checklist of Mendelian randomization study]. Table S2. [Char...
Additional file 1: Table S1. Phenotype descriptions and distributions. Table S2A. Characteristics of...
IBD during follow-up in individuals with a lower GI biopsy result of normal mucosa.</p
Estimated odds of serious infection for treatment strategies compared to aminosalicylates or antibio...
markdownabstractInflammatory Bowel Disease (IBD) is a chronic disabling disease of the gastrointesti...
Estimated odds of serious infection for treatment strategies compared to other immunosuppressants. (...
BACKGROUND: Data evaluating the chronological order of appearance of extraintestinal manifestations ...
Table S1. Characteristics of patients with IBD resident in Tuscany in 2000–2016 (N = 1584). (DOCX 12...
BACKGROUND: Data evaluating the chronological order of appearance of extraintestinal manifestations ...